肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2021 SBCO 指南：中低位直肠癌手术治疗

2021-09-28 巴西肿瘤外科学会 Whely

消化道肿瘤中低位直肠癌

结直肠癌 (CRC) 是北美、西欧和巴西的第三大癌症病因，是一个重要的公共卫生问题。据估计，大约 30% 的 CRC 病例对应于位于直肠的肿瘤，需要复杂的多学科治疗。

中文标题：

2021 SBCO 指南：中低位直肠癌手术治疗

英文标题：

Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer

发布机构：

巴西肿瘤外科学会

发布日期：

2021-09-28

简要介绍：

结直肠癌 (CRC) 是北美、西欧和巴西的第三大癌症病因，是一个重要的公共卫生问题。据估计，大约 30% 的 CRC 病例对应于位于直肠的肿瘤，需要复杂的多学科治疗。为了向治疗直肠癌的外科医生提供基于文献中最佳证据的最新信息，巴西肿瘤外科学会 (SBCO) 制定了本直肠癌治疗指南，重点关注相关的主要主题到日常临床实践。

相关资料下载：
[AttachmentFileName(sort=1, fileName=巴西外科肿瘤学会：中低位直肠癌手术治疗指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7811c1c00232a32e, title=2021 SBCO 指南：中低位直肠癌手术治疗, enTitle=Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer, guiderFrom=Whely, authorId=0, author=, summary=结直肠癌 (CRC) 是北美、西欧和巴西的第三大癌症病因，是一个重要的公共卫生问题。据估计，大约 30% 的 CRC 病例对应于位于直肠的肿瘤，需要复杂的多学科治疗。, cover=https://img.medsci.cn/2022117/1642435125721_5579292.jpg, journalId=0, articlesId=null, associationId=2310, associationName=巴西肿瘤外科学会 , associationIntro=巴西肿瘤外科学会 (SBCO), copyright=0, guiderPublishedTime=Tue Sep 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #1c1d1e;">结直肠癌 (CRC) 是北美、西欧和巴西的第三大癌症病因，是一个重要的公共卫生问题。</span><span style="color: #1c1d1e;">据估计，大约 30% 的 CRC 病例对应于位于直肠的肿瘤，需要复杂的多学科治疗。</span><span style="color: #1c1d1e;">为了向治疗直肠癌的外科医生提供基于文献中最佳证据的最新信息，巴西肿瘤外科学会 (SBCO) 制定了本直肠癌治疗指南，重点关注相关的主要主题到日常临床实践。</span></p>, tagList=[TagDto(tagId=439, tagName=消化道肿瘤), TagDto(tagId=116468, tagName=中低位直肠癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=7, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5474, appHits=157, showAppHits=0, pcHits=367, showPcHits=5317, likes=0, shares=32, comments=5, approvalStatus=1, publishedTime=Mon Jan 17 23:53:50 CST 2022, publishedTimeString=2021-09-28, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Jan 17 23:56:32 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 02:10:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=巴西外科肿瘤学会：中低位直肠癌手术治疗指南.pdf)])
巴西外科肿瘤学会：中低位直肠癌手术治疗指南.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188942, encodeId=5643118894206, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79fa5708317, createdName=ms9000002102609454, createdTime=Fri Jan 28 20:54:45 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185537, encodeId=a9af118553e8d, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Tue Jan 18 10:21:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185472, encodeId=ec3d11854e2cc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Jan 18 07:23:39 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185402, encodeId=619611854028b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/81a13c005a58c36e2844559604049d14.jpg, createdBy=444c2087018, createdName=等待热奶茶, createdTime=Tue Jan 18 00:23:46 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-28 ms9000002102609454

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188942, encodeId=5643118894206, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79fa5708317, createdName=ms9000002102609454, createdTime=Fri Jan 28 20:54:45 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185537, encodeId=a9af118553e8d, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Tue Jan 18 10:21:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185472, encodeId=ec3d11854e2cc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Jan 18 07:23:39 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185402, encodeId=619611854028b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/81a13c005a58c36e2844559604049d14.jpg, createdBy=444c2087018, createdName=等待热奶茶, createdTime=Tue Jan 18 00:23:46 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 萌宝嘟嘟

    好东西，谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188942, encodeId=5643118894206, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79fa5708317, createdName=ms9000002102609454, createdTime=Fri Jan 28 20:54:45 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185537, encodeId=a9af118553e8d, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Tue Jan 18 10:21:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185472, encodeId=ec3d11854e2cc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Jan 18 07:23:39 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185402, encodeId=619611854028b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/81a13c005a58c36e2844559604049d14.jpg, createdBy=444c2087018, createdName=等待热奶茶, createdTime=Tue Jan 18 00:23:46 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 微探

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188942, encodeId=5643118894206, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79fa5708317, createdName=ms9000002102609454, createdTime=Fri Jan 28 20:54:45 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185537, encodeId=a9af118553e8d, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Tue Jan 18 10:21:46 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185472, encodeId=ec3d11854e2cc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Jan 18 07:23:39 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185402, encodeId=619611854028b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/81a13c005a58c36e2844559604049d14.jpg, createdBy=444c2087018, createdName=等待热奶茶, createdTime=Tue Jan 18 00:23:46 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 等待热奶茶

    学习了

    0

相关指南

日本胰腺导管腺癌伴腹膜播散临床实践指南概要

日本肝胆胰腺外科学会(JSHBPS,Japanese Society of Hepato-Biliary-Pancreatic Surgery) · 2021-12-02

钇90微球管理专家共识

中国抗癌协会肿瘤介入学专业委员会 · 2021-06-10

2022 ASCRS临床实践指南：结肠癌的治疗

美国结肠和直肠外科医师学会(ASCRS,American Society of Colon and Rectal Surgeons) · 2022-01-10

中国整合胃癌前病变临床管理指南

中华中医药学会脾胃病分会 · 2021-02-25

2021更新版—2020 NICE指南：结直肠癌（NG.151）

英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence) · 2021-12-15

2021 TSCRS共识：转移性结直肠癌的治疗

台湾结直肠外科医师学会(TSCRS,Taiwan Society of Colon and Rectal Surgeons) · 2021-11-15